… treatment between Cisplatin (cDDP) and Selenocystine (SeC) may improve the therapeutic
effect against liver cancer … increase of RAD51 level treated by cDDP can be suppressed by …

… were all increased after CH1027 treatment lung cancer cells. … as new chemotherapeutic
agents for clinical cancer therapy. … lung cancer and displays resistance to anticancer treatments…

… , selenium supplementation increased the risk of one type of skin cancer (squamous cell
carcinoma) … For example, the anticonvulsant drug valproic acid and the chemotherapeutic agent …

… Chemotherapy is the treatment of cancer with one or more cytotoxic anti-neoplastic drugs
(chemotherapeutic agents) … that compounds 3, 4, and 7 are the potent derivatives to enhance …

… response via the mismatch repair protein hMLH1 in colorectal cancer cells[J]. J Biol Chem, …
selenium and green tea improves the efficacy of chemoprevention in a rat colorectal cancer …

… relationship between selenium and the risk for oral cancer. … of newly diagnosed primary oral
cancer from the First Affiliated … selenium is a protective factor for the incidence of oral cancer…

… How to use the world's scarce selenium resources efficiently to increase the selenium
concentration in food[J]. Microbial Ecology in Health and Disease, 2007, 19(4): 209-228. doi: …

… of the compound could be improved. So, it acts as an important privileged scaffold that widely
exists in the drugs … and aliphatic diselenides are suitable selenium sources in this reaction. …

… Notably, it is shown that activation of ferroptosis could potently inhibit tumor growth and
increase sensitivity to chemotherapy and immunotherapy in various cancer settings. As a result, …

… Percentage increase of SOSG fluorescence intensities from different liposome samples …
compounds. By exploiting the precision of radiation and the potency of chemotherapeutic agents, …